Heard at #CPHI: VC funding trends; Samsung eyes expansion; and supply chain diversificationnews2023-10-27T11:18:51+00:00October 27th, 2023|Endpoints News|
Flagship’s Montai Health hires first CMO; Finance leader to retire at J&J partner Xencornews2023-10-27T10:42:37+00:00October 27th, 2023|Endpoints News|
Prime Medicine showcases its first in vivo editing data in monkeys and micenews2023-10-27T10:00:37+00:00October 27th, 2023|Endpoints News|
Santhera’s vamorolone bags FDA approval for Duchenne after long journeynews2023-10-27T09:56:58+00:00October 27th, 2023|Endpoints News|
Eli Lilly wins FDA approval for mirikizumab in ulcerative colitisnews2023-10-27T08:11:35+00:00October 27th, 2023|Endpoints News|
Sanofi will spin out consumer unit, putting weight behind R&D effortsnews2023-10-27T05:30:14+00:00October 27th, 2023|Endpoints News|
Study: Oncologists who take pharma money are more likely to provide low-value treatmentsnews2023-10-26T19:47:03+00:00October 26th, 2023|Endpoints News|
Klick Health hires market access chief with Big Pharma résuménews2023-10-26T19:14:52+00:00October 26th, 2023|Endpoints News|
Lawmakers push for faster, conditional FDA approval pathway for rare disease drugsnews2023-10-26T19:13:50+00:00October 26th, 2023|Endpoints News|
UK regulators warn against fake Ozempic and Saxenda pensnews2023-10-26T19:05:19+00:00October 26th, 2023|Endpoints News|
